The comparison of genotyping, antibiogram, and antimicrobial resistance genes between carbapenem-susceptible and -resistant Acinetobacter baumannii

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 37, Issue 5-6, 2014, Pages 339-346

  Chen, Chih Ming ^a,b   Ke, Se Chin ^a   Li, Chia Ru ^a   Chang, Chao Chin ^b  

^a TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Acinetobacter baumannii; Carbapenem resistant; Carbapenem susceptible; MLST; PFGE

Indexed keywords

AMIKACIN; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; CARBAPENEM SUSCEPTIBLE ACINETOBACTER BAUMANNII; CHILD; COMPARATIVE STUDY; FEMALE; GENOTYPE; HUMAN; INTEGRON; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; VERY ELDERLY; ACINETOBACTER INFECTION; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION; GENETICS; INFANT; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PLASMID; PRESCHOOL CHILD;

ACINETOBACTER BAUMANNII;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION; GENOTYPE; HUMANS; INFANT; INTEGRONS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; PLASMIDS;

EID: 84922810505     PISSN: 01479571     EISSN: 18781667     Source Type: Journal    
DOI: 10.1016/j.cimid.2014.10.002     Document Type: Article

References (37)

1. Go E.S., Urban C., Burns J., Kreiswirth B., Eisner W., Mariano N., et al. Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 1994, 344:1329-1332.
2. Su C.H., Wang J.T., Hsiung C.A., Chien L.J., Chi C.L., Yu H.T., et al. Increase of carbapenem-resistant Acinetobacter baumannii infection in acute care hospitals in Taiwan: association with hospital antimicrobial usage. PLoS One 2012, 7:e37788.
3. Tseng S.H., Lee C.M., Lin T.Y., Chang S.C., Chuang Y.C., Yen M.Y., et al. Combating antimicrobial resistance: antimicrobial stewardship program in Taiwan. J Microbiol Immunol Infect 2012, 45:79-89.
4. Chen C.M., Liu P.Y., Ke S.C., Wu H.J., Wu L.T. Investigation of carbapenem-resistant Acinetobacter baumannii isolates in a district hospital in Taiwan. Diagn Microbiol Infect Dis 2009, 63:394-397.
5. Poirel L., Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006, 12:826-836.
6. Higgins P.G., Dammhayn C., Hackel M., Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 2010, 65:233-238.
7. Higgins P.G., Poirel L., Lehmann M., Nordmann P., Seifert H.O.X. A-143 a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 2009, 53:5035-5038.
8. Higgins P.G., Perez-Llarena F.J., Zander E., Fernandez A., Bou G., Seifert HOXA-235 a novel class D beta-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 2013, 57:2121-2126.
9. Hall R.M., Collis C.M. Antibiotic resistance in gram-negative bacteria: the role of gene cassettes and integrons. Drug Resist Updat 1998, 1:109-119.
10. Huang L.Y., Chen T.L., Lu P.L., Tsai C.A., Cho W.L., Chang F.Y., et al. Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan. Clin Microbiol Infect 2008, 14:1010-1019.
11. Turton J.F., Kaufmann M.E., Glover J., Coelho J.M., Warner M., Pike R., et al. Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom. J Clin Microbiol 2005, 43:3074-3082.
12. Bartual S.G., Seifert H., Hippler C., Luzon M.A., Wisplinghoff H., Rodriguez-Valera F. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 2005, 43:4382-4390.
13. Chuang Y.C., Sheng W.H., Lauderdale T.L., Li S.Y., Wang J.T., Chen Y.C., et al. Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan. J Microbiol Immunol Infect 2014, 47:324-332.
14. Shen G.H., Wang J.L., Wen F.S., Chang K.M., Kuo C.F., Lin C.H., et al. Isolation and characterization of phikm18p, a novel lytic phage with therapeutic potential against extensively drug resistant Acinetobacter baumannii. PLoS One 2012, 7:e46537.
15. Lee M.H., Chen T.L., Lee Y.T., Huang L., Kuo S.C., Yu K.W., et al. Dissemination of multidrug-resistant Acinetobacter baumannii carrying Bla(OxA-23) from hospitals in central Taiwan. J Microbiol Immunol Infect 2013, 46:419-424.
16. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16:128-140.
17. Chen T.L., Siu L.K., Wu R.C., Shaio M.F., Huang L.Y., Fung C.P., et al. Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumannii. Clin Microbiol Infect 2007, 13:801-806.
18. CLSI Performance standards for antimicrobial susceptibility testing, twenty first informational supplement M100-S21 2011, Clinical and Laboratory Standards Institute, Wayne, PA.
19. Magiorakos A.P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18:268-281.
20. Bickley J., Owen R.J. Preparation of bacterial genomic DNA. Methods Mol Biol 1995, 46:141-147.
21. Woodford N., Ellington M.J., Coelho J.M., Turton J.F., Ward M.E., Brown S., et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006, 27:351-353.
22. Pitout J.D., Gregson D.B., Poirel L., McClure J.A., Le P., Church D.L. Detection of Pseudomonas aeruginosa producing metallo-beta-lactamases in a large centralized laboratory. J Clin Microbiol 2005, 43:3129-3135.
23. Gautom R.K. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other gram-negative organisms in 1 day. J Clin Microbiol 1997, 35:2977-2980.
24. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
25. Diancourt L., Passet V., Nemec A., Dijkshoorn L., Brisse S. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 2010, 5:e10034.
26. Chu Y.W., Leung C.M., Houang E.T., Ng K.C., Leung C.B., Leung H.Y., et al. Skin carriage of Acinetobacters in Hong Kong. J Clin Microbiol 1999, 37:2962-2967.
27. Chen M.Z., Hsueh P.R., Lee L.N., Yu C.J., Yang P.C., Luh K.T. Severe community-acquired pneumonia due to Acinetobacter baumannii. Chest 2001, 120:1072-1077.
28. Leung W.S., Chu C.M., Tsang K.Y., Lo F.H., Lo K.F., Ho P.L. Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest 2006, 129:102-109.
29. OXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis 2010, 16:35-40.
30. Heritier C., Poirel L., Nordmann P. Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin Microbiol Infect 2006, 12:123-130.
31. OXA-23 gene in imipenem-susceptible Acinetobacter baumannii. Mem Inst Oswaldo Cruz 2011, 106:505-506.
32. Lu P.L., Doumith M., Livermore D.M., Chen T.P., Woodford N. Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase. J Antimicrob Chemother 2009, 63:641-647.
33. Wu K., Wang F., Sun J., Wang Q., Chen Q., Yu S., et al. Class 1 integron gene cassettes in multidrug-resistant Gram-negative bacteria in southern China. Int J Antimicrob Agents 2012, 40:264-267.
34. Hwa W.E., Subramaniam G., Navaratnam P., Sekaran S.D. Detection and characterization of class 1 integrons among carbapenem-resistant isolates of Acinetobacter spp. in Malaysia. J Microbiol Immunol Infect 2009, 42:54-62.
35. Poirel L., Naas T., Nordmann P. Diversity, epidemiology, and genetics of class D beta-lactamases. Antimicrob Agents Chemother 2010, 54:24-38.
36. Poirel L., Bonnin R.A., Nordmann P. Genetic basis of antibiotic resistance in pathogenic Acinetobacter species. IUBMB Life 2011, 63:1061-1067.
37. Levesque C., Piche L., Larose C., Roy P.H. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 1995, 39:185-191.